Cellular distribution and relative amounts of vascular endothelium growth factor mRNA in granulosa cells from human preovulatory follicles

European Cytokine Network

Volumn 10, Issue 3, 1999, Pages 393-401

  Machelon, Véronique ^a   Nome, Françcoise ^a  

^a INSERM   (France)

Author keywords

Granulosa; Ovary; Preovulatory follicle; VEGF

Indexed keywords

CHORIONIC GONADOTROPIN; MESSENGER RNA; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BIOTINYLATION; BLOOD VESSEL PERMEABILITY; CELL CULTURE; CELLULAR DISTRIBUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERTILIZATION IN VITRO; FLOW CYTOMETRY; GRANULOSA CELL; HUMAN; HUMAN CELL; LEUKOCYTE; OVARY FOLLICLE; OVULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; BASE SEQUENCE; DNA PRIMERS; ENDOTHELIAL GROWTH FACTORS; ENZYME INHIBITORS; FEMALE; FOLLICULAR PHASE; GRANULOSA CELLS; HUMANS; LYMPHOKINES; PROTEIN KINASE C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032858503     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Ferrara N, David-Smith T. 1997. The biology of vascular endothelial growth factor. (Review) Endocr. Rev. 18: 4.
2. Ferrara N, Houck K, Jakeman L, Leung D W. 1992. Molecular and biological properties of the vascular endothelial growth factor family of proteins. (Review) Endocr. Rev. 13: 18.
3. Koos R D. 1993. Ovarian angiogenesis. In: Adshi E Y, Leung P C, eds. The ovary. New York: Raven Press, 443.
4. Suzuki T, Sasano H, Takaya R, Fukaya T, Yajima A, Nagura H. 1998. Cyclic changes of vasculature and vascular phenotypes in normal human ovaries. Hum. Reprod. 13: 953.
5. Redmer D A, Reynolds L P. 1996. Angiogenesis in the ovary. (Review) Rev. Reprod. 1: 182.
6. Machelon V, Emilie D. 1997. Production of ovarian cytokines and their role in ovulation in the mammalian ovary. (Review) Eur. Cytokine Netw. 8: 137.
7. Ferrara N, Chen H, Davis-Smyth T, Gerber H P, Nguyen T N, Peers D, Chisholm V, Hillan K J, Schwall R H. 1998. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat. Med. 4: 336.
8. Koos R D. 1995. Increased expression of vascular endothelial growth/permeability factor in the rat ovary following an ovulatory gonadotropin stimulus: potential roles in follicle rupture. Biol. Reprod. 52: 1426.
9. Gordon J D, Mesiano S, Zaloudek C J, Jaffe R B. 1996. Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. J. Clin. Endocrinol. Metab. 81: 353.
10. Agrawal R, Conway G, Sladkevicius P, Tan S L, Engmann L, Payne N, Bekir J, Cambell S, Jacobs H. 1998. Serum vascular endothelium growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystics ovaries. Fertil Steril. 70: 651.
11. Agrawal R, Sladkevicius P, Engmann L, Conway G S, Payne N N, Bekis J, Tan S L, Cambell S, Jacobs H S. 1998. Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries. Hum. Reprod. 13: 651.
12. Elchalal U, Schenker J G. 1997. The pathophysiology of ovarian hyperstimulation syndrome - views and ideas. (Review) Hum. Reprod. 12: 1129.
13. Rizk B, Aboulghar M, Smitz J, Ron-El R. 1997. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. (Review) Hum. Reprod. Update 3: 255.
14. Levin E R, Rosen G F, Cassidenti D L, Yee B, Meldrum D, Wisot A, Pedram A. 1998. Role of vascular endothelial growth factor in ovarian hyperstimulation syndrome. J. Clin. Invest. 102: 1978.
15. Artini P G, Fasciani A, Monti M, Luisi S, D'Ambrogio G, Genazzani A R. 1998. Changes in vascular endothelium growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program. Fertil Steril. 70: 560.
16. Paley P J, Staskus K A, Gebhard K, Mohanraj D, Twiggs L B, Carson L F, Ramakrishnan S. 1997. Vascular endothelial growth factor in early stage ovarian carcinoma. Cancer 80: 98.
17. Yoneda J, Kuniyasu H, Crispens M A, Price J E, Bucana C D, Fidler I L. 1998. Expression of angiogenesis-related genes and progresssion of human ovarian carcinomas in nude mice. J. Natl. Cancer Inst. 90: 447.
18. Fujimoto J, Sakaguchi H, Hirose R, Ichigo S, Tamaya T. 1998. Biologic implications of the expression of vascular endothelium growth factor subtypes in ovarian carcinoma. Cancer 83: 2528.
19. Yamamoto S, Konishi I, Tsuruta Y, Nanbu K, Mandai M, Kuroda H, Matsushita K, Humid A A, Yura Y, Mori T. 1997. Expression of vascular endothelium growth factor (VEGF) during folliculogenesis and corpus luteum formation in the human ovary. Gynecol. Endocrinol. 11: 371.
20. Shweiki D, Itin A, Neufels G, Gitay-Goren H, Keshet E. 1993. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J. Clin. Invest. 91: 2235.
21. Christenson L K, Stouffer R L. 1997. Follicle-stimulating hormone and luteinizing hormone/chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre- and periovulatory follicles. J. Clin. Endocrinol. Metab. 82: 2135.
22. Lee A, Christenson L K, Stouffer R L, Burry K A, Paton P E. 1997. Vascular endothelial growth factor levels in serum and follicular fluid of patient undergoing in vitro fertilization. Fertil Steril. 68: 305.
23. Moncayo H E, Penz-Koza A, Marth C, Gastl G, Herold M, Moncayo R. 1998. Vascular endothelial growth factor in serum and in the follicular fluid of patients undergoing hormonal stimulation for in vitro fertilization. Hum. Reprod. 13: 3310.
24. Yan Z, Weich H A, Bernart W. Breckwlodt M, Neulen J. 1993. Vascular endothelial growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulosa cells in vito. J. Clin. Endocrinol. Metab. 77: 1723.
25. Kamat B R, Brown L F, Manseau E J, Senger D R, Dvorak H F. 1995. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus lutein development. Am. J. Pathol. 146: 157.
26. Laitinen M, Ristimäki A, Honkosalo M, Narko K, Paavonen K, Ritvos O. 1997. Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells. Endocrinology 138: 4748.
27. Lee A, Christenson L K, Patton P E, Burry K A, Stouffer R L. 1997. Vascular endothelium growth factor production by human luteinized granulosa cells in vitro. Hum. Reprod. 12: 2756.
28. Machelon V, Nomé F, Durand-Gasselin I, Emilie D, 1997. Tumor necrosis factor-α induces interleukin-6 mRNA and protein in human granulosa luteinizing cells via protein tyrosine kinase without involving ceramide. Mol. Cell. Endocrinol. 126: 173.
29. Fukuoka M, Yasuda K, Taii S, Takakura K, Mori T. 1989. Interleukin-1 stimulates growth and inhibits progesterone secretion in cultures of porcine granulos cells. Endocrinology 124: 884.
30. Yamamoto T, Mori S, Yoneyama M, Imanishi M, Takleuchi M. 1998. Evaluation of rat sperm by flow cytometry: simultaneous analysis of sperm count and sperm viability. J. Toxicol. Sci. 23: 373.
31. Beckmann M W, Polacek D, Seung L, Schreiber J R. 1991. Human ovarian granulosa cell culture: determination of blood cell contamination and evaluation of possible culture purification steps. Fert. Steril. 56: 881.
32. Torry D S, Holt V J, Keenan J A, Harris G, Caudle M R, Torry R J. 1996. Vascular endothelial growth factor expression in cycling human endometrium. Fertil Steril. 66: 72.
33. Ishii Y. 1995. Expression and subtype analysis of vascular endothelial growth factor and its receptor (flt-1) in human ovarian tumors. Nippon Sanka Fujinka Gakkai Zasshi 47: 133.
34. Soker S, Gollamudi-Payne S, Fidder H, Charmahelli H, Klagsbrun M. 1997. Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF 165. J. Biol. Chem. 272: 31582.
35. Charnock-Jones D S, Sharkey A M, Rajput-Williams J, Burch D, Schofield J P, Fountain S A, Boocock C A. Smith S K. 1993. Identification and localizalion of alternatively spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol. Reprod. 48: 1120.
36. Poltorak Z, Cohen T, Sivan R, Kandelis Y, Spira G, Vlodavsky I, Keshet E, Neufeld G. 1997. VEGF 145, a secreted vascular endothelial growth factor isoform that binds to extra-cellular matrix. J. Biol. Chem. 272: 7151.
37. Houck K A, Leung D W, Rowland A M, Winer J, Ferrara N. 1992. Dual regulation of vascular endothelial growth factor bio-availability by genetic and proteolytic mechanism. J. Biol. Chem. 267: 26031.
38. Dissen G A, Lara H E, Fahrenbach W H, Costa ME, Ojeda S R. 1994. Immature rat ovaries become revascuralized rapidly after autotransplantation and show a gonadotropindependent increase in angiogenic factor gene expression. Endocrinology 134: 1146.
39. Veldhuis J D, Garmey J C, Urban R J, Demers L M, Aggarwal B B. 1991. Ovarian actions of tumor necrosis factor-α (TNF-α): pleiotropic effects of TNF-α on differentiated functions of untransformed swine granulosa cells. Endocrinology 129: 641.
40. Vilcek J, Lee T H. 1991. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. (Review) J. Biol. Chem. 266: 7313.
41. Heller R A, Krönke M. 1994. Tumor necrosis factor receptor-mediated signaling pathways. (Review) J. Cell Biol. 126: 5.
42. Li X, Youngblood G L, Payne A H, Hales D B. 1995. Tumor necrosis factor-α inhibition of 17α-hydroxylase/C17-20 lyase gene (Cyp 17) expression. Endocrinology 136: 3519.
43. Zachow R J, Terranova P F. 1993. Involvement of protein kinase C and protein tyrosine kinase pathways in tumor necrosis factor-α-induced clustering of ovarian theca-interstitial cells. Mol. Cel. Endocrinol. 97: 37.
44. Diaz-Meco M T, Berra E, Municio M M, Sanz L, Lozano J, Dominguez I, Diaz-Golpe V, Lain de Lera M T, Alcami J, Paya C V, et al. 1993. A dominant negative protein kinase C zeta subspecies blocks NF-kappa B activation. Mol. Cell. Biol. 13: 4770.
45. Belfiore C J, Hawkins D E, Wiltbank M C, Niswender G D. 1994. Regulation of cytochrome P450scc synthesis and activity in the ovine corpus luteum. J. Steroid Biochem. Mol. Biol. 51: 283.
46. Kaminski T, Akinola L, Poutanen M, Vihko R, Vinko P. 1997. Growth factors and phorbol-12-myristate-13-acetate modulate the follicle-stimulating hormone and cyclic adenosine-3′-5′-monophosphate-dependent regulation of 17beta-hydroxysteroid dehydrogenasc type 1 expression in rat granulosa cells. Mol. Cell. Endocrinol. 136: 47.
47. Goede V, Schmidt T, Kimmina S, Kozian D, Augustin H G. 1998. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis, Lab. Invest. 78: 1385.
48. Steele G L, Leung P C. 1993. Signal transduction mechanisms in ovarian cells. In: Adashi E Y, Leung P C K, eds. The ovary. New York: Raven Press, 11.
49. Gillim S W, Christensen K A, McLennan C E. 1969. Fine structure of the human menstrual corpus luteum at its stage of maximum secretory activity. Am. J. Anat. 126: 409.
50. Best C L, Pudney J, Welch W R, Burger N, Hill J A. 1996. Localization and characterization of white blood cell populations within the human ovary throughout the menstrual cycle and menopause. Hum. Reprod. 11: 790.
51. Takaya R, Fukaya T, Sasano H, Suzuki T, Tamura M, Yajima A. 1997. Macrophages in normal cycling human ovaries: immunohistochemical localizalion and characterization. Hum. Reprod. 12: 1508.